La Jolla, CA, United States of America

Duane J Knize

USPTO Granted Patents = 1 

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Duane J Knize: Innovator in Bioagent Detection

Introduction

Duane J Knize is a notable inventor based in La Jolla, California. He has made significant contributions to the field of bioagent detection through his innovative patent. His work focuses on methods and apparatus for genetic evaluation, which has important implications for various industries.

Latest Patents

Duane J Knize holds a patent for "Methods and apparatus for genetic evaluation." This patent describes a process for rapid and definitive bioagent detection and identification without the need for nucleic acid sequencing. The technology allows for the analysis of various bioagents and samples, including air, fluid, and body samples. This analysis provides valuable information for industrial, medical, and environmental purposes. The process involves collecting nucleic acid samples of unknown or suspected bioagents, selecting optimal primer pairs, and amplifying the nucleic acid. Expected mass spectra signal models are generated, and the actual mass spectra of the amplicons are obtained. A joint maximum likelihood analysis is used to determine the expected mass spectra that most closely correlates with the actual mass spectra, leading to the identification of the most likely candidate bioagents.

Career Highlights

Duane J Knize is associated with Ibis Biosciences, Inc., where he applies his expertise in bioagent detection. His innovative approach has positioned him as a key figure in the development of advanced detection methods.

Collaborations

Some of his notable coworkers include David J Ecker and Richard Holmes Griffey. Their collaboration has contributed to the advancement of technologies in the field of bioagent detection.

Conclusion

Duane J Knize's work in bioagent detection exemplifies the impact of innovative thinking in addressing complex challenges. His patent and contributions to Ibis Biosciences, Inc. highlight the importance of advancements in genetic evaluation for various applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…